Acerus Pharma

Mississauga, Canada Founded: 2008 • Age: 18 yrs
Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments.
Request Access

About Acerus Pharma

Acerus Pharma is a company based in Mississauga (Canada) founded in 2008. It operates as a B2B. Acerus Pharma has raised $38.07 million across 14 funding rounds from investors including MidCap Financial, SWK Holdings and Quantius. Acerus Pharma has completed 2 acquisitions, including Serenity and Serenity Pharmaceuticals. Acerus Pharma operates in a competitive market with competitors including Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.

  • Headquarter Mississauga, Canada
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $38.07 M (USD)

    in 14 rounds

  • Latest Funding Round
    $18 M (USD), Post-IPO

    Feb 12, 2020

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
    Serenity

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Acerus Pharma
Headcount 10-50
Employee Profiles 1
Board Members and Advisors 4
Board Members and Advisors
people
Borys Chabursky
Director
people
Stephen Gregory
Director
people
Ian Ihnatowycz
Chairman

Unlock access to complete

Funding Insights of Acerus Pharma

Acerus Pharma has successfully raised a total of $38.07M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $18 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 14
  • Last Round Post-IPO — $18.0M
  • First Round

    (11 Apr 2011)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2020 Amount Post-IPO - Acerus Pharma Valuation

investors

Jul, 2019 Amount Debt – Conventional - Acerus Pharma Valuation

investors

Mar, 2019 Amount Post-IPO - Acerus Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Acerus Pharma

Acerus Pharma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include MidCap Financial, SWK Holdings and Quantius. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment services are offered by First Generation Capital.
Founded Year Domain Location
Private debt funds are managed across multiple sectors.
Founded Year Domain Location
Investments and advisory services are provided by the holding company.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Acerus Pharma

Acerus Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Serenity and Serenity Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutics for voiding disorders are developed by Serenity.
2006
Novel therapeutics using unique delivery mechanisms combined with low threshold efficacious formulations
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Acerus Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Acerus Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Acerus Pharma

Acerus Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for women's healthcare are developed and offered.
domain founded_year HQ Location
Developer of therapeutics and drug-device combinations for urology and sexual health
domain founded_year HQ Location
Developer of drugs for women's health and pain management
domain founded_year HQ Location
Microchip implants for wireless drug delivery are developed.
domain founded_year HQ Location
A proprietary oral testosterone replacement therapy platform is developed.
domain founded_year HQ Location
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Acerus Pharma

Frequently Asked Questions about Acerus Pharma

When was Acerus Pharma founded?

Acerus Pharma was founded in 2008 and raised its 1st funding round 3 years after it was founded.

Where is Acerus Pharma located?

Acerus Pharma is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.

Is Acerus Pharma a funded company?

Acerus Pharma is a funded company, having raised a total of $38.07M across 14 funding rounds to date. The company's 1st funding round was a Post-IPO of $4.53M, raised on Apr 11, 2011.

What does Acerus Pharma do?

Acerus Pharma, based in Mississauga, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and urology and hormone therapy. Develops pharmaceuticals for urology, hormone replacement therapy, and female sexual dysfunction treatments. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

Who are the top competitors of Acerus Pharma?

Acerus Pharma's top competitors include Agile Therapeutics, Lipella and Auxilium Pharmaceuticals.

How many acquisitions has Acerus Pharma made?

Acerus Pharma has made 2 acquisitions, including Serenity, and Serenity Pharmaceuticals.

Who are Acerus Pharma's investors?

Acerus Pharma has 4 investors. Key investors include MidCap Financial, SWK Holdings, Quantius, and First Generation Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available